κ-Opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: Relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids

Brain Research

Volumn 737, Issue 1-2, 1996, Pages 175-187

  Gurwell, Julie A ^a,d   Duncan, Marilyn J ^a   Maderspach, Katalin ^b   Stiene Martin, Anne ^a   Elde, Robert P ^c   Hauser, Kurt F ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cell division; Central nervous system maturation; Drug abuse; Endogenous opioid system; Fura 2; Intracellular calcium; Neuroglia; Nifedipine; Nor binaltorphimine; Opioid receptor; Thapsigargin; U50488H; U69593

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BROXURIDINE; FURA 2; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NIFEDIPINE; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; THAPSIGARGIN;

ARTICLE; ASTROCYTE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ABUSE; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

EID: 0030597164     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00728-7     Document Type: Article

References (80)

1. [1] Arvidsson, U., Riedl, M., Chakrabarti, S., Vulchanova, L., Lee, J.-H., Nakano, A.H., Lin, X., Loh, H.H., Law, P.-Y., Wessendorf, M.W. and Elde, R., The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc. Natl. Acad. Sci. USA, 92 (1995) 5062-5066.
2. 3H]thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnover, J. Neurochem., 60 (1993) 1505-1511.
3. 2+ mobilization in rat C6 glioma cells, J. Neurosci., 14 (1994) 5858-5864.
4. [4] Barg, J., Nah, S.-Y., Levy, R., Saya, D. and Vogel, Z., Modulation of thymidine incorporation by kappa-opioid ligands in rat spinal cord-dorsal root ganglion co-cultures, Brain Res., 629 (1993) 109-114.
5. [5] Barg, J. and Simantov, R., Transient expression of opioid receptors in defined regions of developing brain: are embryonic receptors selective. J. Neurochem., 57 (1991) 1978-1984.
6. [6] Berridge, M.J., Inositol trisphosphate and calcium signalling, Nature, 361 (1993) 315-325.
7. [7] Berzetei-Gurske, I.P., White, A., Polgar, W., DeCosta, B.R., Pasternak, G.W. and Toll, L., The in vitro pharmacological characterization of naloxone benzoylhydrazone, Eur. J. Pharmacol., 277 (1995) 257-263.
8. [8] Bourne, H.R. and Stryer, L., The target sets the tempo, Nature, 358 (1992) 541-543.
9. [9] Bouger, A. and Spruce, B.A., Proenkephalin is a nuclear protein responsive to growth arrest and differentiation signals, J. Cell Biol., 130 (1995) 1251-1262.
10. [10] Crain, S.M. and Shen, K.F., Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons, Trends Pharmacol. Sci., 11 (1990) 77-81.
11. [11] Cruciani, R.A., Dvorkin, B., Morris, S.A., Grain, S.M. and Makman, M.H., Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells, Proc. Natl. Acad. Sci. USA, 90 (1993) 3019-3023.
12. [12] Doberczak, T.M., Kandall, S.R. and Wilets, I., Neonatal opiate abstinence syndrome in term and preterm infants, J. Pediatr., 118 (1991) 933-937.
13. [13] Egan, T.M. and North, R.A., Both μ and δ opiate receptors exist on the same neuron, Science, (1981) 923-924.
14. [14] Eriksson, P.S., Hansson, E. and Rönnbäck, L., δ and kappa opiate receptors in primary astroglial cultures. Part II: Receptor sets in cultures from various brain regions and interactions with β-receptor activated cyclic AMP, Neurochem. Res., 17 (1992) 545-551.
15. 2+ channels, Neuroscience, 54 (1993) 401-407.
16. [16] Evans, C.J. Diversity among the opioid receptors. In S.G. Korenman and J.D. Barchas (Eds.), Biological Basis of Substance Abuse, Oxford University Press, New York, 1993, pp. 31-48.
17. [17] Fields, A., Gafni, M., Oron, Y. and Sarne, Y., Multiple effects of opiates on intracellular calcium levels and on calcium uptake in three neuronal cell lines, Brain Res., 687 (1995) 94-102.
18. [18] Finkbeiner, S.M., Glial calcium, Glia, 9 (1993) 83-104.
19. [19] Gillberg, C., Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians, Dev. Med. Child Neurol., 37 (1995) 239-245.
20. [20] Gorodinsky, A., Barg, J., Belcheva, M.M., Levy, R., Mchale, R.J., Vogel, Z. and Coscia, C.J., Dynorphins modulate DNA synthesis in fetal brain cell aggregates, J. Neurochem., 65 (1995) 1481-1486.
21. [21] Grynkiewicz, G., Poenic, M. and Tsien, R.Y., A new generation of calcium indicators with greatly improved fluorescence properties, J. Biol. Chem., 2603440 (1985) 3440-3450.
22. [22] Gurwell, J.A. and Hauser, K.F., Morphine does not affect astrocyte survival in developing primary mixed-glial cultures, Dev. Brain Res., 76 (1993) 293-298.
23. [23] Hammer Jr., R.P., Effects of opioids on the developing brain. In R.P. Hammer, Jr. (Ed.) The Neurobiology of Opiates, CRC Press, Boca Raton, FL, 1993, pp. 1-21.
24. [24] Hauser, K.P. and Mangoura, D., Diversity of the endogenous opioid system in development: novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation, Perspect. Dev. Neurobiol., (1996) in press.
25. [25] Hauser, K.F., Osborne, J.G., Stiene-Martin, A. and Melner, M.H., Cellular localization of proenkephalin mRNA and enkephalin peptide products in cultured astrocytes. Brain Res., 522 (1990) 347-353.
26. [26] Hauser, K.F. and Stiene-Martin, A., Characterization of opioid-dependent glial development in dissociated and organotypic cultures of mouse central nervous system: critical periods and target specificity, Dev. Brain Res., 62 (1991) 245-255.
27. [27] Hauser, K.F. and Stiene-Martin, A., Opiates and the regulation of nervous system development: evidence from in vitro studies. In R.P. Hammer Jr. (Ed.), Neurobiology of Opiates, CRC Press, Boca Raton, Florida, 1993, pp. 23-61.
28. 2- -dependent mechanism, Brain Res., 720 (1996) 191-203.
29. [29] Jin, W., Lee, N.M., Loh, H.H. and Thayer, S.A., Opioid-induced inhibition of voltage-gated calcium channels parallels expression of omega-conotoxin-sensitive channel subtype during differentiation of NG108-15 cells, Brain Res., 607 (1993) 17-22.
30. [30] Kaltenbach, K.A. and Finnegan, L.P., Prenatal narcotic exposure: perinatal and developmental effects, Neurotoxicology, 10 (1989) 597-604.
31. [31] Klein, R.S. and Fricker, L.D., Heterogeneous expression of carboxy-peptidase E and proenkephalin mRNAs by cultured astrocytes, Brain Res., 569 (1992) 300-310.
32. 3H]U-69.593 a highly selective ligand for the κ opioid receptor, Eur. J. Pharmacol. 109 (1985) 281-284.
33. [33] Leng, G., Bicknell, R.J., Brown, D., Bowden, C., Chapman, C. and Russell, J.A., Stimulus-induced depletion of pro-enkephalins, oxytocin and vasopressin and pro-enkephalin interaction with posterior pituitary hormone release in vitro. Neuroendocrinology, 60 (1994) 559-566.
34. [34] Leslie, F.M. and Loughlin, S.E., Development of multiple opioid receptors. In M.W. Miller (Ed.), Development of the Nervous System: Effects of Alcohol and Opiates, Wiley-Liss, New York, 1992,
35. [35] Leslie, F.M. and Loughlin, S.E., Ontogeny and plasticity of opioid systems. In R.P. Hammer Jr. (Ed.), The Neurobiology of Opiates, CRC Press, Boca Raton, FL, 1993. pp. 85-123.
36. [36] Maderspach, K. and Németh, K., Immunocytochemical visualization of kappa-opioid receptors on chick embryonic neurons differentiating in vitro, Neuroscience, 57 (1993) 459-465.
37. [37] Maderspach, K., Németh, K., Simon, J., Benyhe, S., Szües, M. and Wollemann, M., A monoclonal antibody recognizing κ-but not μ-and δ-opioid receptors, J. Neurochem., 56 (1991) 1897-1904.
38. [38] Maderspach, K. and Solomonia, R., Glial and neuronal opioid receptors: apparent positive cooperatively observed in intact cultured cells, Brain Res., 441 (1988) 41-47.
39. [39] Maderspach, K., Takács, J., Niewiadomska, G. and Csillag, A., Postsynaptic and extrasynaptic localization of kappa-opioid receptor in selected brain areas of young rat and chick using an anti-receptor monoclonal antibody, J. Neurocytol., 24 (1995) 478-486.
40. [40] Mangoura, D. and Dawson, G., Chronic opioid treatment attenuates carbachol-mediated polyphosphoinositide hydrolysis in chick embryo neuronal cultures, Brain Res., 548 (1991) 273-278.
41. [41] Mangoura, D. and Dawson, G., Opioid peptides activate phospholipase D and protein kinase C-∈ in chicken embryo neuron cultures, Proc. Natl. Acad. Sci. USA, 90 (1993) 2915-2919.
42. [42] Means, A.R., Calcium, calmodulin and cell cycle regulation, FEBS Lett., 347 (1994) 1-4.
43. [43] Melner, M.H., Low, K.G., Allen, R.G., Nielson, C.P., Young, S.L. and Saneto, R.P., The regulation of proenkephalin expression in a distinct population of glial cells, EMBO J., 9 (1990) 791-796.
44. [44] Minami, M. and Satoh, M., Molecular biology of the opioid receptors: structures, functions and distributions, Neurosci. Res., 23 (1995) 121-145.
45. [45] Muller, C.M., Glial cells and activity-dependent central nervous system plasticity. In H. Kettenmann and B.R. Ransom (Eds.), Neuroglia, Oxford Univ. Press, New York, 1995, pp. 805-814.
46. [46] Neer, E.J., Heterotrimeric G proteins: organizers of transmembrane signals, Cell, 80 (1995) 249-257.
47. [47] Osborne, J.G., Kindy, M.S., Spruce, B.A. and Hauser, K.F., Ontogeny of proenkephalin mRNA and enkephalin peptide expression in the cerebellar cortex of the rat: spatial and temporal patterns of expression follow maturational gradients in the external granular layer and in Purkinje cells, Dev. Brain Res., 76 (1993) 1-12.
48. 14C]deoxyglucose incorporation into glycogen, Neurosci. Lett., 55 (1985) 157-160.
49. α subunit and is similar to that of other opioid receptors, Mol. Brain Res., 29 (1995) 336-346.
50. [50] Raff, M.C., Abney, R.E., Cohen, J., Lindsay, R. and Noble, M., Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface ganagliosides and growth characteristics, J. Neurosci., 3 (1983) 1289-1300.
51. [51] Rakic, P., Radial glial cells: scaffolding for brain construction. In H. Kettenmann and B.R. Ransom (Eds.), Neuroglia, Oxford Univ. Press, New York, 1995, pp. 746-762.
52. [52] Reddy, G.P., Cell cycle: regulatory events in G1 → S transition of mammalian cells, J. Cell Biochem., 54 (1994) 379-386.
53. [53] Reisine, T., Opiate receptors, Neuropharmacology, 34 (1995) 463-472.
54. [54] Rius, R.A., Barg, J., Bem, W.T., Coscia, C.J. and Loh, Y.P., The prenatal developmental profile of expression of opioid peptides and receptors in the mouse brain, Dev. Brain Res., 58 (1991) 237-241.
55. [55] Ruzicka, B.B., Fox, C.A., Thompson, R.C., Meng, F., Watson, S.J. and Akil, H., Primary astroglial cultures derived from several rat brain regions differentially express μ, δ and κ opioid receptor mRNA. Mol. Brain Res., 34 (1995) 209-220.
56. [56] Ruzicka, B.B., Thompson, R.C., Watson, S.J. and Akil, H., Interleukin-1 β-mediated regulation of μ-opioid receptor mRNA in primary astrocyte-enriched cultures, J. Neurochem., 66 (1996) 425-428.
57. [57] Schmidt, P., Schöder, H., Maderspach, K. and Staak, M., Immunohistochemical localization of κ opioid receptors in the human frontal cortex, Brain Res., 654 (1995) 223-233.
58. [58] Schwartz, J.P., Nishiyama, N., Wilson, D. and Taniwaki, T., Receptor-mediated regulation of neuropeptide gene expression in astrocytes, Glia, 11 (1994) 185-190.
59. [59] Shao, Y. and McCarthy, K.D., Plasticity of astrocytes, Glia, 11 (1994) 147-155.
60. [60] Shinoda, H., Marini, A.M., Cosi, C. and Schwartz, J.P., Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes, Science, 245 (1989) 415-417.
61. [61] Shinoda, H., Marini, A.M. and Schwartz, J.P., Developmental expression of the proenkephalin and prosomatostatin genes in cultured cortical and cerebellar astrocytes, Dev. Brain Res., 67 (1992) 205-210.
62. [62] Simon, E.J. and Hiller, J.M., Opioid peptides and opioid receptors. In G.J. Siegel, B.W. Agranoff, R.W. Albers and P.B. Molinoff (Eds.), Basic Neurochemistry, Raven Press, New York, 1994, pp. 321-339.
63. [63] Spruce, B.A., Curtis, R., Wilkin, G.P. and Glover, D.M., A neuropeptide precursor in cerebellum: proenkephalin exists in subpopulations of both neurons and astrocytes, EMBO J., 9 (1990) 1787-1795.
64. [64] Stiene-Martin, A., Gurwell, J.A. and Hauser, K.F., Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neural maturation, Dev. Brain Res., 60 (1991) 1-7.
65. [65] Stiene-Martin, A. and Hauser, K.F., Opioid-dependent growth of glial cultures: suppression of astrocyte DNA synthesis by Met-enkephalin, Life Sci., 46 (1990) 91-98.
66. [66] Stiene-Martin, A. and Hauser, K.F., Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro, J. Neurosci. Res., 29 (1991) 538-548.
67. [67] Stiene-Martin, A., Mattson, M.P. and Hauser, K.F., Opiates selectively increase intracellular calcium in developing type-1 astrocytes: role of calcium in morphine-induced morphologic differentiation, Dev. Brain Res., 76 (1993) 189-196.
68. [68] Takemori, A.E., Ho, B.Y., Naeseth, J.S. and Portuguese, P.S., Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays, J. Pharmacol. Exp. Ther., 246 (1988) 255-258.
69. [69] Thorlin, T., Eriksson, P.S., Nilsson, M., Hansson, E. and Rönnbäck, L., Co-localized opioid and glutamate receptors on astroglial cells - possible regulators of synaptic transmission, Soc. Neurosci. Abstr., 20 (1994) 1731.
70. 2 receptors by a computerized model-fitting technique, Mol. Pharmacol., 37 (1990) 694-703.
71. [71] Vaysse, P.J.-J., Zukin, R.S., Fields, K.L. and Kessler, J.A., Characterization of opioid receptors in cultured neurons, J. Neurochem., 55 (1990) 624-631.
72. [72] Vernadakis, A., Sakellaridis, N., Geladopoulos, T. and Mangoura, D., Function of opioids early in embryogenesis, Ann. NY Acad. Sci., 579 (1990) 109-122.
73. [73] Vilijn, M.H., Vaysse, P.J.-J., Zukin, R.S. and Kessler, J.A., Expression of preproenkephalin mRNA in cultured astrocytes and neurons, Proc. Natl. Acad. Sci. USA, 85 (1988) 6551-6555.
74. [74] Wang, L. and Gintzler, A.R., Bimodal opioid regulation of cyclic AMP formation: implications for positive and negative coupling of opiate receptors to adenylyl cyclase, J. Neurochem., 63 (1994) 1726-1730.
75. [75] Werz, M.A. and Macdonald, R.L., Heterogeneous sensitivity of cultured dorsal root ganglion neurones to opioid peptides selective for mu-and delta-opiate receptors, Nature, 299 (1982) 730-733.
76. [76] Wilkin, G.P., Marriott, D.R. and Pearce, B., Peptide receptors on astrocytes. In H. Kettenmann and B.R. Ransom (Eds.), Neuroglia, Oxford Univ. Press, New York, 1995, pp. 367-376.
77. [77] Wollemann, M., Benyhe, S. and Simon, J., The kappa-opioid receptor: evidence for the different subtypes, Life Sci., 52 (1993) 599-611.
78. [78] Zagon, I.S., Goodman, S.R. and McLaughlin, P.J., Zeta (ζ), the opioid growth factor receptor: identification and characterization of binding subunits, Brain Res., 605 (1993) 50-56.
79. [79] Zagon, I.S. and McLaughlin, P.J., Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system, Brain Res., 542 (1991) 318-323.
80. [80] Zamboni, L. and De Martino, C., Buffered picric acid formaldehyde: a new rapid fixative for electron microscopy, J. Cell Biol., 35 (1967) 148A.